Effective January 1, 2023, Michelle LeCointe was elected to partnership at Seed IP Law Group LLP, having previously served for two years as Of Counsel in the firm’s Biotechnology, Pharmaceuticals & Chemistry Group. Michelle's practice centers on U.S. and international IP strategies and patent procurement as well as IP agreements for a broad array of technologies, with a focus on pharmaceuticals, biologics, medical devices, and rechargeable batteries. She also has substantial experience in corporate IP due diligence, U.S. and international post-grant contested proceedings, non-infringement and invalidity opinions, and patent litigation. Michelle received a B.A. (magna cum laude) in Biochemical Sciences from Harvard University, in 1997. She received her J.D. from Columbia Law School, as a Harlan Fiske Stone Scholar, in 2000.

Michelle is admitted to the state bars of Washington, New York and Texas. She is registered to practice before the United States Patent and Trademark Office and the United States District Court for the Western District of Texas. Michelle is a member of the Washington State Patent Law Association (WSPLA), the Austin Intellectual Property Law Association, and Life Science Washington.

Learn more about Michelle LeCointe.

Seed IP congratulates Michelle on her promotion to partner!

‍